Successful sorafenib treatment for metastatic renal cell carcinoma in a case with chronic renal failure
- PMID: 19004541
- DOI: 10.1016/j.eururo.2008.10.027
Successful sorafenib treatment for metastatic renal cell carcinoma in a case with chronic renal failure
Abstract
Treatment options for patients with end-stage renal disease (ESRD) and metastatic renal cell carcinoma (mRCC) are limited. We report the case of a 69-yr-old male who was treated with sorafenib after failure of immunotherapy. The treatment has resulted in remission with stable disease for 13 mo so far. Sorafenib seems to be a safe treatment option for patients with ESRD and mRCC, but further studies are required.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical